Senti Biosciences is trading 5.39% down now at $0.42 after closing at $0.45 on August 14, with no confirmed August 17 company-specific catalyst identified.
- Shares gained 16.93% during the August 14 regular session.
- The company reported a second-quarter net loss of $12.75 million after the August 14 close.
- Six-month net loss was $16.97 million; the report did not explicitly connect results to the stock move.